The risk of pocket infection or bloodstream infection following central venous port placement for the patients with Cetuximab therapy.
Shintaro SueyoshiTakeharu OnoShun-Ichi ChitoseMioko FukahoriTakashi KuritaHirohito UmenoPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Skin complications after the central venous port placement were related to cetuximab administration and the timing of cetuximab therapy.